The US FDA discloses a June 22nd warning letter to Sanofi's (SAN FP) Genzyme after a facility inspection

#FRANCE#EUROPE#SANOFI#SAN.FP#BANCO SANTANDER SA#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#DIVERSIFIED BANKS#PHARMACEUTICALS (GROUP)#BANKS#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#BANKS (GROUP)#SAN#EURO STOXX 50#CAC 40 INDEX#SANOFI SA#CAC
Published: Updated: